Study reveals a non-linear, inverted U-shaped association between preoperative BMI and optimal weight loss outcomes post bariatric surgery. Setting a BMI threshold of 42.9 is critical in predicting optimal clinical responses in patients with obesity. Quartile odds ratios and restricted cubic spline analysis support this correlation, highlighting the importance of personalized treatment strategies based on preoperative BMI levels.
Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).
Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.
